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Summary.-An experimental tumour system for the study of metastasis has been
developed using a syngeneically transplanted murine squamous carcinoma of
spontaneous origin. Implants of the tumour, which does not elicit a significant
immune response, grew and metastasized regularly to regional lymph nodes and
lungs, in a manner comparable with that of the more malignant types of human
epithelioma.
The system has been used to test the influence of pre-operative irradiation,
regional lymph node excision, tumour biopsy and manipulation, on metastasis.
Of these, only pre-operative irradiation with 2000 rad 24 h before tumour excision
produced a significant differential effect-a lower incidence of metastasis. By
contrast, local radiation therapy sufficient to cause complete tumour regression but
insufficient to achieve long-term local cure was shown to result in accelerated
metastasis. A highly significant inhibition of metastasis was observed with the
drug ICRF 159, but histological features suggested that its anti-metastatic effect
in this system did not depend on morphological changes which might prevent
dissemination of tumour cells.
ALTHOUGH failure to achieve local
control of human cancers has been
estimated to contribute to the death of
about one-third of cancer patients (Suit,
1969), the major cause of failure in cancer
therapy is metastatic disease. Further-
more, it is highly likely that if new
techniques lead to increased local tumour
control, many of the patients concerned
will subsequently succumb to metastases.
This depressing conclusion is of course
due to the establishment of metastases in
the pre-clinical phase of tumour growth.
A simplified consideration of the life
history of a tumour growing exponentially
from a single mutant cell indicates that
about 26 population doublings are neces-
sary before the tumour reaches a mean
diameter of 5 mm (i.e. near the limit for
clinical diagnosis) while only another 14
doublings are needed to produce a usually
lethal tumour mass of 1 kg (Collins,
Loeffler and Tivey, 1956). While it is
true that the growth rate ofmany tumours
may decelerate when they reach clinical
proportions, the example given illustrates
the fact that a very large part of the total
duration of a neoplasm is subelinical, and
it is therefore not surprising that many
tumours have already metastasized when
first diagnosed. Nonetheless, clinical
experience has shown that perhaps the
best single prognostic criterion in cancer is
the clinical stage or the size ofthe tumour
mass at the time of presentation. One is
therefore forced to conclude that the risk
of established metastatic disease increases
rather dramatically in the clinical or
immediate preclinical phase of growth,
and cancer therapists must face the fact
that they may influence the probability
of metastasis by their management. In
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principle, it should be easy to assess the
risks ofa particular procedure by reference
to controlled animal studies, but in prac-
tice no animal tumour system can
adequately represent the human problem
in every detail.
The most notable objections to the
validity of many experimental tumours
as models of human cancer are (i) the
existence of powerful antigenic differences
between tumour and host, often involving
transplantation antigens; (ii) patterns of
local growth and metastasis (or lack ofit),
which are often quite unrepresentative of
human cancer; (iii) a frequent lack of
histological resemblance to the commonly
occurring human neoplasms; and (iv) very
rapid growth rates. The first 3 of these
major objections are overcome in a system
which has been developed from a murine
squamous carcinoma and the model has
been used to investigate some of the
factors which have variously been alleged
to influence metastasis. In addition, the
natural history of the tumour has been
studied in relation to its metastatic
behaviour (Peters, 1975).
MATERIALS AND METHODS
Mice and tumour.-Female mice of the
inbred albino strain WHT/Ht were used
throughout these experiments. The tumour,
designated Sq. Ca. " G ", arose spontaneously
in the forestomach of a female mouse of the
WHT/Ht strain in October 1970 and has
since been maintained by serial subcutaneous
transplantation and by storage in liquid N2.
Histologically, the tumour is a squamous
cell carcinoma which showed extensive
keratinization early in its transplant history,
but for the greater part ofthe duration ofthe
experiments described in this paper (repre-
senting passage numbers 53-99) it has been
less well differentiated, though readily recog-
nizable as a squamous carcinoma.
Quantitative transplantation assays ofthe
tumour by the subcutaneous route show a
TD50 (mean number of viable tumour cells
required to achieve50% " takes ") of200-300
cells when viable cells are injected alone, and
2-7 cells when viable cells are injected in
association with an excess of lethally irra-
diated (LI) cells. The transplantation kin-
etics of the tumour are consistent with single
cell transplantation when excess LI cells are
admixed, but are " anomalous " (Porter,
Hewitt and Blake, 1973) when viable cells
are injected alone, i.e. upwards of 104 cells
are required for 100% successful transplan-
tation.
In both circumstances, the median latent
period between injection of cells and the
formation of palpable tumours is inversely
correlated with the logarithm of the number
of viable cells injected.
In the experiments described in this
paper, transplantation was performed intra-
dermally. An inoculum of 105 cells in
0-01 mlproduced, onaverage, discoidtumours
ofabout 120 mm3 in 10 days. However, due
in part to variable leakage ofthe cell suspen-
sion from a superficial intradermal injection,
a spread oflatent periods often occurred. In
the experiments involving regional lymph
node excision and putative immunization a
reduced inoculum of about 2 x 104 cells was
used to produce a longer exposure to tumour
growth before a specific size was attained.
Preliminary experiments with the tumour
system showed that local excision ofprimary
implants in the first 5 days after inoculation,
or when the tumour was no larger than
20 mm3, resulted in no metastases within
a 150-day observation period. On the other
hand, no mouse in which the primary implant
reached a size of 200 mm3 or more, irrespec-
tive of its duration of growth, failed to
develop metastases. For this reason, and to
increase the analogy with human tumours
which present as a function ofsize rather than
duration, it was decided to use tumour size
as the criterion for randomizing mice into
their appropriate experimental group. Sub-
sequent analysis of the data, however,
indicated that the correlation of size with
metastatic risk was not statistically signifi-
cant within the range employed (Peters,
1975).
The choice of a tumour size range which
resulted in an intermediate risk of metastasis
permitted the detection of either increased
or decreased risk with different procedures.
The primary inoculation site was on the
left flank of the mouse, from which met-
astasis, when itoccurred, wasmost commonly
to the lungs and mediastinum (97% of cases)
and to the ipsilateral axillary lymph node
(35%/). Mice which developed thoracic met-
astases were prone to sudden death due to
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erosion of the great vessels, but whenever
possible mice were killed when they developed
respiratory distress, when a metastatic node
reached a size of IO0 cm diameter, or when
other evidence of metastatic disease declared
itself. All mice were autopsied to record
the extent of metastatic disease and in the
course of the experiments involving 280
autopsies, macroscopic metastatic deposits
were observed in ovaries (10 cases), liver (6
cases), and kidney, adrenal, brain and bone
(1 each). For the purposes of analysis, mice
killed for humane reasons in a preterminal
state are treated as having " died " on the
same day.
Metastases were classified as predomi-
nantly thoracic or predominantly lymph
nodal, according to which site was directly
responsible for death or sacrifice of the
mouse. Survivors were observed for at
least 150 days and some for up to 12 months.
In the whole series of experiments, 280 inice
developed metastatic disease: of these, only
2 had a disease-free interval exceeding 100
days, so that survival for 150 days was
reasonably regarded as " cure ". No mice
died of causes other than metastatic disease.
Tests for tumour immunogenicity.-Mice
were subjected to live cell " immunization "
either by excision of a growing tumour 10
days after implantation (at a size of
30-50 mm3) or by subthreshold intradermal
inoculations of live tumour cells. Fourteen
days after the initial cell injection, the
" immunized " mice and an age-matched
group of untreated controls were challenged
with subcutaneous injections of viable cells
with or without added radiation killed cells.
The tumour take incidence and median latent
periods for palpable tumour development
were recorded.
Irradiations.-Local tumour irradiations
were performed 4 at a time, using a Westing-
house x-ray machine (250 kVp; 15 mA;
1-3 mm Cu h.v.l.; 494 rad/min). Mice were
lightly sedated with tribromethanol (Avertin)
150 mg/kg s.c. and were placed in individual
lead boxes which had been specially con-
structed to allow the flap of skin bearing the
tumour to be drawn out from the box onto
a perspex stage during the irradiation. The
flap was loosely tethered to a central pillar
to prevent retraction but care was taken to
avoid tension which could have altered blood
flow.
Tumour excisions.-Mice were anaesthe-
25
tized with ether and an ellipse of skin includ-
ing the tumour, with 3-5 mm margins, was
excised. The cutaneous site of tumour
implantation allowed clean and complete
excision, and only 12/342 mice developed
local recurrence.
Axillary lymphadenectomy.-An arcuate
incision was made along the lower border of
the pectoralis major and the muscle was
lifted forwards to expose the axilla. One
large node was regularly present in relation
to the axillary vein and in some instances
a smaller second node was present. These
were removed by teasing free the fatty tissue
in which they were embedded. The axillary
vein was not removed.
Incision biopsy.-A deep wedge of tissue
including the full diameter of the tumour
plusskinoneithersidewasremoved. Topical
thrombin was applied if necessary to stop
bleeding.
Tumour manipalation.-Tumours were
gently rolled between finger and thumb for
1 min. This caused softening of the tumour
followed by engorgement with blood over the
next 10-15 min.
ICRF 159.-Supplies of the drug were
kindly provided by Dr K. Hellmann of the
Imperial Cancer Research Fund. It was
given at a dose of 30 mg/kg daily i.p. or s.c.
from the time of tumour inoculation till
excision or irradiation.
RESULTS
Effect of " immunization " procedures
The results of attempted tumour
immunization are presented in the Table.
Mice in which a growing tumour had been
excised before challenge showed a slight
reduction in tumour takes compared with
the controls or with mice which had
received previous subthreshold inocula-
tions. None ofthe differences is statistic-
ally significant and no significant pro-
longation of the tumour latent periods
was observed in the " immunized " mice.
It is therefore concluded that the tumour
is non-immunogenic by these criteria as
one would expect for a syngeneically
transplanted tumour of spontaneous
origin.
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TABLE.-Effect of Prior " Immunization "
of Mice on the Subsequent Growth of
Tumours from Challenge Inocula. (The
Method of " Immunization " was either
Excision of a Growing Tumour after
10 days or Subthreshold Intradermal
Injections of Live Tumour Cells. Mice
were Challenged 14 Days after
" Immunization ")
Series I (104 viable cells)
Pretreatment
Nil
Subthreshold intradermal
inoculum
Previous tumour growth
for 10 days
Tumour
incidence
18/20
18/20
17/24
Series II (200 viable cells + 105
lethally-irradiated cells)
Pretreatment
Nil
Subthreshold intradermal
inoculum
Previous tumour growth
for 10 days
Tumour
incidence
15/20
21/24
18/28
Median
latent
period
10 5 days
12*0 days
12- 5 days
Median
latent
period
10 5 days
9* 5 days
10 0 days
Effect ofpre-operative irradiation
Four separate experiments involving
a total of 145 mice were carried out. In
each, tumours were either sham irradiated
or given 500 or 2000 rad on reaching a
,.I I 1
40
20
predetermined size which varied from
about 30-90 mm3, according to the experi-
ment. Theintervalbetweenimplantation
and irradiation varied from 6 to 16 days.
All tumours were excised 24 h after
irradiation. The combined results are
plotted in Fig. 1, where it can be seen that
mice receiving 2000 rad pre-operatively
had a better survival than either of the
other groups. Long-term survival in the
2000 rad group was 20/42 compared with
14/54 in the controls. This difference is
statistically significant (x2 4-86; d.f.1;
P< 0.05). Survival in the 500 rad group
was 13/49. The patterns of metastatic
disease within the groups showed no signi-
ficant difference, with predominantly
thoracic metastases accounting for 72.5%
of deaths in the controls, 66.7% in the
500 rad group and 77.3% in the 2000 rad
group.
Effect of regional lymphadenectomy
Two experiments involving 58 mice
were performed. In each, a reduced
inoculum was used to permit a longer
period of exposure of the regional node
to tumour before excision was performed.
A size of 90 mm3 was chosen which was
reached in 10-29 days after implantation.
oW~~~~~~~~ o
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FIG. 1.-Effect of pre-operative irradiation with 2000 rad ( ) or 500 rad (- ---) 24 h
before tumour excision on the subsequent development of metastatic disease.
.I ....... -t.
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Matched pairs of mice whose tumours
reached the reference volume on the same
day were allocated randomly to the
lymphadenectomy or sham operated con-
trol group giving 29 mice in each group.
Axillary dissection was done immediately
before tumour excision. The results show
no significant difference in survival
(8/29 dissected and 9/29 controls) and
the patterns of metastasis were similar,
with predominantly thoracic metastases
in 9000 of mice dying in the dissected
group and 9500 ofthe controls. Curiously,
there was a relative deficiency of axillary
metastases in the sham operated mice
compared with other control groups.
This is very likely a chance observation
although it is possible that alterations in
lymph flow after surgery could be
implicated.
Effect of tumour manipulation
In 3 experiments involving 33 mice
(16 controls, 17 manipulated) 60 or 90 mm3
tumours were used, with growth periods of
8-20 days. Mice were allocated randomly
to manipulation or control groups as
their tumours reached the reference
volume. Manipulation was performed as
described in the Materials and Methods
section, and excision wasperformed 15 min
later. This time was designed to simulate
rough handling of a tumour during
operative excision. The results show no
significant difference in survival (5/17
manipulated and 4/16 controls). While
there was an increased incidence of nodal
metastases in the manipulated group
(25% c.f. 0%O), the difference is not
statistically significant (x2 3X69; d.f.1;
P> 0.05) with the numbers of mice
available.
Effect of incisional biopsy
Two experiments involving 38 mice
were performed. Tumours which had
been growing for 9-13 days were biopsied
as described in the Materials and Methods
section at a size of 60 or 90 mm3.
Excisions were performed 24 h later on
matched pairs of mice (19 per group).
The results show no difference in survival
between the two groups (5/19 in both) and
the difference in metastatic pattern-
64% predominantly thoracic in the biopsy
group vs 78% in the controls was not
significant.
Effect of non-curative irradiation
Radiation studies on the tumour
system (to be reported elsewhere) indicated
that the mean curative dose (TCD50) for
tumours of about 90 mm3 was around
5000 rad. The fate of mice with tumours
in the size range 60-120 mm3 was deter-
mined according to whether they received
a dose of 4500 rad (i.e. low probability
ofcure) or 5500-6000 rad (high probability
of cure). Both doses were sufficient to
cause complete regression of tumours and
only those mice in which the primary
tumour site was macroscopically clear
at the time of death were scored for the
development ofmetastases. This analysis,
Fig. 2, showed that mice receiving a
statistically non-curative dose had a
shorter median survival time and poorer
long-term survival (0/29) than mice locally
"cured " by radiation (9/28) or a third
group treated by surgical excision (4/25).
The implication is that microscopic recur-
rence of tumour contributed to the
development of distant metastases (see
Discussion).
Effect of ICRF 159
In the course ofexperiments performed
in collaboration with Dr W. Boggust of
St Luke's Hospital, Dublin, to assess the
anti-metastatic potential ofvarious chelat-
ing agents, a pilot study of the effect of
ICRF 159 was carried out which indicated
that the drug inhibited metastases in this
system. Subsequent experiments con-
firming this finding are presented here.
Mice were treated with daily injections
of 30 mg/kg i.p. or s.c. from the time of
tumour implantation until they reached
a size of 110-125mm3 8-10 days later.
Tumours were then either surgically
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FIG. 2.-Effect of radiation therapy suifficient to cause complete macroscopic regression of a tumour
but adequate to achieve long-term cure (- ) compared with locally curative irradiation
(-0--) or excision (------) on the subsequent development of metastases.
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t
-0 10 20 30 40 50
TIME AFTER THERAPY (DAYS)
i, /
60 70 I' IS0
FIG. 3.-Effect of ICRF 159 30 mg/kg daily i.p. or s.c., from the time of tumour implantation till
locally curative treatment on the subsequent development of metastases.
excised or ablated with radiation. Of
these mice, 29/40 were long-term survivors
compared with 0/8 in a concurrent control
group (Fig. 3). The overall survival of
control mice from all experiments was
44/179. This is significantly poorer than
the survival rate for ICRF 159 treated
mice (X2 33-8; d.f.1; P < 0-001). The
growth rate of primary tumour implants
was not appreciably affected by the drug;
the mean delay in reaching the specified
size in the treated group was <1 day
compared with the controls. Histological
examination of tumours from ICRF 159
treated and control mice was made for
the features described by Salsbury,
Burrage and Hellmann (1970) and James
and Salsbury (1974) in the Lewis lung
tumour. The degree of haemorrhage at
the growing margin of the tumour, the
presence of sinusoidal tumour cell-lined
blood spaces and the extent of muscle
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FIG. 4.-Sections from the growing edge of tumours in mice treated with ICRF 159 30 mg/kg/day
from the day of tumour cell injection till the day of excision. Panel (a) shows tumour cells lining
a sinusoidal blood filled space in the centre-left of the picture. Interstitial haemorrhage is also
present. Panel (b) shows active invasion ofmuscle by the advancing tumour. These appearances
do not support the proposition that ICRF 159 acts to prevent access of tumour cells to the circu-
lation. H. and E. x 250.L. J. PETERS
invasion were assessed. This author was
unable to find any consistent differences
in these features (Fig. 4), nor was there
any difference between the appearances of
the primary growths in ICRF 159 treated
mice which did or did not develop metas-
tases. Further consideration ofthis topic
is found in the Discussion.
DISCUSSION
Whether or not a diagnostic or thera-
peutic manoeuvre influences the prob-
ability of metastasis of a particular
tumour will depend on the unique rela-
tionship between that tumour and its
host. Extrapolation of data from one
species to another, or even generalization
concerning cancer of a particular site or
histology in man, can be misleading. Yet
to obtain insight into the risks of various
procedures necessitates one or other of
these approaches. When animal tumour
systems are employed, biological variables
can be closely controlled and accumula-
tion of data is relatively easy, so that
" significant " resultsare obtainable. But
before accepting " significant " results
from animal systems it is of paramount
importance to ensure that the tumour-
host system used is a reasonable model of
human cancer. Such a claim can be made
for the system used in these experiments.
Two important findings deserve com-
ment in relation to previously reported
results: firstly, that regional lympha-
denectomy does not adversely affect
survival and secondly, that pre-operative
radiation is likewise not harmful and may
actually be beneficial in terms of survival.
Concerning the role of the regional
lymph node, the experimental work of
Crile (1965, 1968) is frequently quoted.
Of the systems he used, however, one is
allogeneic (Sarcoma 180 in non-inbred
" Swiss " mice), where H2 locus trans-
plantation antigens were so powerful that
30% ofuntreated micerejectedthetumour
and even then the regional node was of
unique significance only in the period
4-10 days after tumour implantation.
Clearly such a system cannot be con-
sidered a fair model ofhuman cancer. In
2 other systems, nominally isologous but
lacking substrain specificity, a direct
comparison of radical and simple surgery
showed a difference in the incidence of
distant metastases in only one and here,
again, the time ofsurgery was critical.
McCredie, Inch and Cowie (1972)
found that excision or irradiation of
regional lymph nodes 20 days after
tumour implantation was without effect
on the metastasis of either strongly or
weakly antigenic tumours, while Ham-
mond andRolley (1970), using a syngeneic,
chemically induced mouse sarcoma which
was weakly immunogenic, could not
display any differences in local recurrence
or distant metastasis between mice under-
going regional lymphadenectomy and con-
trols. The present experiments, using a
spontaneously arising, syngeneically trans-
planted squamous carcinoma with a
range of exposure times, also show no
adverse effect of regional lymphadenec-
tomy, leading one to conclude that experi-
mental evidence from representative
animal tumours does not support the view
that potentially involved regional lymph
nodes should be left untreated.
A discussion of the question of pre-
operative irradiation in relation to the
development of metastases has recently
been provided by Scott (1972), who
identified many of the problems inherent
in interpreting clinical and experimental
studies. Nickson and Glicksman (1972)
lamented the fact that the published
experimental data " involve host-tumour
reactions which may result from non-
isogenic tumours as well as other factors
which may be at issue. . . . The
tumour system used in these experiments
is free of this criticism as it arose spon-
taneously and has been maintained in a
strictly syngeneic substrain of mice. No
deleterious effect of pre-operative irradia-
tion was observed: indeed 2000 rad given
24 h before excision was positively benefi-
cial. These results are in accord with
those of Sheldon (1974) who studied a
slowly growing syngeneic mouse sarcoma
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of spontaneous origin, as well as those of
several other workers (see Perez, 1970.)
Reports of increased metastases attribut-
able to irradiation fall into 2 main groups:
(i) situations where the tumours in
unirradiated controls have reached such
massive sizes as to cause constitutional
depletion (e.g. Kaplan and Murphy, 1949);
(ii) studies involving tumours which infil-
trate diffusely rather than grow as
stromated tumours (e.g. van den Brenk
and Sharpington, 1971). The consensus
of data from experiments which more
closely simulate the majority of human
cancer leads to the conclusion that the
local benefits of pre-operative irradiation
need not be sacrificed for fear ofpromoting
metastases.
Mechanical disturbance ofthe primary
tumour by biopsy or manipulation did not
significantly influence metastases in this
tumour system. In general, clinical
experience supports this view, e.g. Griffiths
et al. (1972) found no correlation between
the presence of malignant cells in peri-
pheral or local venous blood during
resection of colonic and rectal cancers
and the subsequent development ofmetas-
tases, although histological evidence of
venous invasion did carry a worse prog-
nosis. Growth of tumour into veins very
likely increases the risk of dissemination
oflarge emboli oftumour cells, which have
been shown experimentally to be more
efficient than single cells in establishing
" metastases " (Thompson, 1974), and
it is logically prudent to avoid unnecessary
rough handling of all neoplasms. Biopsy
of cancers for diagnostic and prognostic
purposes is generally accepted as a justifi-
able procedure although the potential
hazardofopeningintovesselsisrecognized.
Clinical experience with squamous cell
carcinomata at various sites, as well as the
present experimental results, suggests that
these tumours can be biopsied with
impunity. In the case of malignant
melanomata, radical excision is usually
performed on the basis of a clinical
diagnosis, for fear of increasing the risk
of metastases. However, the evidence
to support such a policy is tenuous:
Jones et al. (1968) and Epstein, Bragg and
Linden (1969) both found no evidence of
an adverse prognosis in patients whose
malignant melanomata were biopsied or
locally excised before more radical treat-
ment.
The effect ofnon-curative radiation on
the development of metastases is most
interesting. Suit, Sedlacek and Gillette
(1970) and more recently Sheldon et al.
(1974) reported an increased incidence of
metastasis in C3H mice which developed
recurrent mammary tumours after irradia-
tion; thisincidence wasreducedbysurgical
excision of the recurrent tumour. The
former authors also determined, on the
basis of transplantation assays, that mice
dying of metastasis with no macroscopic
recurrence did not have an increased
incidence of residual subclinical disease.
This conclusion, based on only 11 mice
because of low incidence of animals in
this category, appears to conflict with
the results reported here in which mice
whose primary sites were macroscopically
" clear" after statistically non-curative
irradiation had a worse prognosis than
thosewhichwerelocally " cured " whether
by radiation or surgery. However, the
squamous cell carcinoma used in these
experiments is a highly malignant tumour
which may well metastasize successfully
at an earlier stage in the growth of a
recurrence than the less aggressive C3H
mammary tumour. All these data indi-
cate that failure to achieve local control
of a primary cancer can increase the risk
of metastatic disease and underline the
importance of radical local cure in the
overall strategy ofcancer treatment.
The efficiency with which (ICRF 159
inhibited the development of metastases
in this tumour system is striking. Histo-
logical studies of the Lewis lung tumour
by Salsbury et al. (1970) have indicated
that in mice treated with ICRF 159, the
tumours showed less haemorrhagic ten-
dency at the growing margin, and that
there was a
cc normalization " of the
abnormal, tumour-cell lined blood vessels
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seen in that tumour. This observation
suggested that the drug might act to
prevent access of malignant cells into the
circulation. James and Salsbury (1974)
also reported inhibition ofmuscle invasion
by tumour in mice treated with ICRF 159
at doses of 30 mg/kg/day. In the tumour
system used for these experiments, how-
ever, I could detect no consistent alteration
in any of these features (Fig. 4). This of
course does notpreclude some modification
of the tumour microvasculature by the
drug but does suggest that the morpho-
logical changes seen in the Lewis lung
tumour are not essential for the anti-
metastatic effect of ICRF 159. Although
ICRF 159 has a cytotoxic effect (Sharpe
et al., 1970) it did not significantly delay
the growth of primary tumour implants
in these experiments. One possibility,
that the drug could be significantly more
toxic to cells which have entered the
circulation than to those in a stromated
tumour, was rejected by James and
Salsbury (1974) using arguments based on
drug concentrations in the blood; but the
effectiveness of 5-fluorouracil (Hellman
et al., 1973) in preventing metastases from
the Lewis lung tumour at a dose which
did not retard primary growth suggests a
higher susceptibility of disseminated cells
to that cytotoxic agent. Moreover, the
report of Hellmann, James and Salsbury
(1974) that " artificial " lung metastases
from intravenously injected Lewis lung
tumour cells were inhibited by ICRF 159
seems to provide direct evidence in favour
of some action on the tumour cells after
they have gained access to the circulation.
The same authors, however, contend that
a toxic effect of ICRF 159 on circulating
cells cannot explain the efficacy of treat-
ment during the first 6 days of tumour
growth. This contention rests on the
tenuous proposition that because no
metastases develop in mice having their
primary tumour implant excised in the
first 5-6 days of growth one can assume
that no tumour cells have disseminated
during this time. It seems fair to con-
clude that the mechanism(s) by which
ICRF 159 inhibits metastases in different
systems must remain, for the present, sub
judice.
I should like to thank Dr H. B. Hewitt
for providing the tumour and mice used
in these experiments; Misses E. Blake,
S. Ayres and A. Walder for assistance, at
different times, with the experiments;
and MrM. Stoneforhelpwiththediagrams,
histology and photography. This work
was performed while the author was
supported by the Cancer Research Cam-
paign at the Gray Laboratory, Mount
Vernon Hospital, Northwood, Middlesex.
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